Zusammenfassung
Der Patient P. leidet an einem Cushing-Syndrom. Sein Leben hat sich dramatisch verändert, seit aufgrund eines Tumors in seiner Hypophyse übermäßige Mengen der Stresshormone Kortikotropin (ACTH) und Kortisol freigesetzt werden. Äußerlich ist aus dem einst schlanken Mann ein fettleibiger Mensch geworden. Schlimmer für den Patienten P. sind die psychischen Auswirkungen der Hormonstörung. Seit Beginn der Krankheit ist er gereizt und leidet immer wieder unter depressiven Verstimmungen. Bei der Arbeit kann er sich nur mit Mühe konzentrieren, und sein Gedächtnis lässt ihn immer wieder im Stich. Erst seitdem sich der Patient P. einer Operation unterzogen hat, bei der der Tumor entfernt werden konnte, haben sich seine Hormonspiegel im Blut wieder normalisiert, und die psychischen Symptome haben sich deutlich gebessert.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
7.4 Literatur
Abdel-Malek ZA (2001): Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58: 434–441.
Abercrombie HC, Kalin NH, Thurow ME, Rosenkranz MA, Davidson RJ (2003): Cortisol variation in humans affects memory for emotionally laden and neutral information. Behav Neurosci 117: 505–516.
Abercrombie HC, Speck NS, Monticelli RM (2006): Endogenous cortisol elevations are related to memory facilitation only in individuals who are emotionally aroused. Psychoneuroendocrinology 31: 187–196.
Al’Absi M, Hugdahl K, Lovallo WR (2002): Adrenocortical stress responses and altered working memory performance. Psychophysiology 39: 95–99.
Andreano, Cahill (2006): Glucocorticoid release and memory consolidation in men and women. Psychol. Sci. 17: 466–470.
Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999): The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol160: 1–12.
Ardayfio P, Kim KS (2006): Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav Neurosci 120: 249–256.
Bale TL, Vale WW (2004): CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525–557.
Barden N, Reul JM, Holsboer F (1995): Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 18: 6–11.
Beckner VE, Tucker DM, Delville Y, Mohr DC (2006): Stress facilitates consolidation of verbal memory for a film but does not affect retrieval. Behav Neurosci 120: 518–527.
Born J, Fehm HL, Voigt KH (1986): ACTH and attention in humans: a review. Neuropsychobiology 15: 165–186.
Born J, Fehm HL (1998): Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 106: 153–163.
Born J, Brauninger W, Fehm-Wolfsdorf G, Voigt KH, Pauschinger P, Fehm HL (1987): Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10. Exp Brain Res 67: 85–92.
Born J, Hitzler V, Pietrowsky R, Pauschinger P, Fehm HL (1988): Influences of cortisol on auditory evoked potentials (AEPs) and mood in humans. Neuropsychobiology 20: 145–151.
Born J, Bathelt B, Pietrowsky R, Pauschinger P, Fehm HL (1990): Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP). Psychopharmacology (Berl) 101: 34–38.
Born J, Pietrowsky R, Fehm HL (1998): Neuropsychological effects of vasopressin in healthy humans. Prog Brain Res 119: 619–643.
Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002): Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514–516.
Born J, Rasch B, Gais S (2006): Sleep to remember. Neuroscientist 12: 410–424.
Boyer P (2000): Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl: 24–29.
Brown ES, Woolston J, Frol A, Bobadilla L, Khan DA, Hanczyc M et al (2004): Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55: 538–545.
Buchanan TW, Lovallo WR (2001): Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 26: 307–317.
Buchanan TW, Tranel D, Adolphs R (2006): Impaired memory retrieval correlates with individual differences in cortisol response but not autonomic response. Learn Mem 13: 382–387.
Butler AA (2006): The melanocortin system and energy balance. Peptides 27: 281–290.
Cahill L, Gorski L, Le K (2003): Enhanced human memory consolidation with post-learning stress: interaction with the degree of arousal at encoding. Learn Mem 10: 270–274.
Calvo N, Volosin M (2001): Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Neuroendocrinology 73: 261–271.
Cone RD (2005): Anatomy and regulation of the central melanocortin system. Nat Neurosci 8: 571–578.
Dautzenberg FM, Kilpatrick GJ, Hauger RL, Moreau J (2001): Molecular biology of the CRH receptors — in the mood. Peptides 22: 753–760.
Diorio D, Viau V, Meaney MJ (1993): The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 13: 3839–3847.
Domes G, Heinrichs M, Rimmele U, Reichwald U, Hautzinger M (2004): Acute stress impairs recognition for positive words—association with stress-induced cortisol secretion. Stress 7: 173–181.
Dornbush RL, Nikolovski O (1976): ACTH 4–10 and short-term memory. Pharmacol Biochem Behav 5: 69–72.
Dunn AJ, Berridge CW (1990): Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15: 71–100.
Eichenbaum H (2000): A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1: 41–50.
Elzinga BM, Roelofs K (2005): Cortisol-induced impairments of working memory require acute sympathetic activation. Behav Neurosci 119: 98–103.
File SE, Vellucci SV, Wendlandt S (1979): Corticosterone — an anxiogenic or an anxiolytic agent? J Pharm Pharmacol 31: 300–305.
Gais S, Plihal W, Wagner U, Born J (2000): Early sleep triggers memory for early visual discrimination skills. Nat Neurosci 3: 1335–1339.
Greven HM, de Wied D (1977): Influence of peptides structurally related to ACTH and MSH on active avoidance behaviour in rats. A structure-activity relationship study. Front Horm Res 4: 140–152.
Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S et al (2000): Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 97: 6079–6084.
Hallschmid M, Benedict C, Born J, Fehm HL, Kern W (2004): Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol Behav 83: 55–64.
Heilig M, Koob GF, Ekman R, Britton KT (1994): Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17: 80–85. Beschreibung tierexperimenteller Befunde aus verschiedenen Untersuchungsparadigmen, die auf eine anxiogene Wirkung von CRH und deren Vermittlung durch Rezeptoren im zentralen Kern der Amygdala hinweisen. Es wird angenommen, dass Neuropeptid Y (NP Y) einen anxiolytisch wirkenden Gegenspieler von CRH darstellt, der unter Stresseinfluss überschießende Angstreaktionen zurückreguliert.
Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF (1992): Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 581: 190–197.
Heinrichs SC, Koob GF (2004): Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 311: 427–440.
Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL et al (2006): Do corticosteroids damage the brain? J Neuroendocrinol 18: 393–411.
Het S, Ramlow G, Wolf OT (2005): A meta-analytic review of the effects of acute cortisol administration on human memory. Psychoneuroendocrinology 30: 771–784.
Holsboer F (2001): Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 62: 77–91. Beschreibung verschiedener Aspekte der Hyperaktivität der HHNAchse bei Depression. Es wird die Hypothese vorgestellt, dass die Wirkung klassischer Antidepressiva bei Depression auf der Wiederherstellung einer gestörten negativen Feedbackfunktion der Glukokortikoidrezeptoren beruht. Die Behandlung depressiver Patienten mit CRH-Antagonisten wird als schneller wirksame Alternative bzw. Ergänzung der Therapie mit klassischen Antidepressiva empfohlen.
Jacobs N, Myin-Germeys I, Derom C, Delespaul P, so van OJ, Nicolson NA (2006): A momentary assessment study of the relationship between affective and adrenocortical stress responses in daily life. Biol Psychol 74: 60–66.
Jacobson L, Sapolsky R (1991): The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12: 118–134.
Janke, W, Debus, G (1978): Die Eigenschaftswörterliste EWL. Eine mehrdimensionale Methode zur Beschreibung von Aspekten des Befindens. Göttingen: Hogrefe.
Joels M, Pu Z, Wiegert O, Oitzl MS, Krugers HJ (2006): Learning under stress: how does it work? Trends Cogn Sci 10: 152–158.
Keck ME, Holsboer F (2001): Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 22: 835–844.
Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL (2001): Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 74: 270–280.
Kirschbaum C, Pirke KM, Hellhammer DH (1993): The ‘Trier Social Stress Test’ — a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28: 76–81.
Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996): Stress and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58: 1475–1483.
de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998): Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269–301. Umfassender Überblick über die Neuroendokrinologie der MR und GR und ihr Zusammenspiel unter normalen und pathologischen Bedingungen. Den Mineralokortikoidrezeptoren wird eine „proaktive“ Rolle zur Aufrechterhaltung basaler Aktivität der HHN-Achse zugeschrieben, den Glukokortikoidrezeptoren eine „reaktive“ Rolle für die Beendigung stressinduzierter Überaktivität des Systems.
Kuhlmann S, Piel M, Wolf OT (2005): Impaired memory retrieval after psychosocial stress in healthy young men. J Neurosci 25: 2977–2982.
Kuhlmann S, Kirschbaum C, Wolf OT (2005): Effects of oral cortisol treatment in healthy young women on memory retrieval of negative and neutral words. Neurobiol Learn Mem 83: 158–162.
Kuhlmann S, Wolf OT (2006): Arousal and cortisol interact in modulating memory consolidation in healthy young men. Behav Neurosci120: 217–223.
Lai JC, Evans PD, Ng SH, Chong AM, Siu OT, Chan CL et al. (2005): Optimism, positive affectivity, and salivary cortisol. Br J Health Psychol 10: 467–484.
Lang PJ, Öhman A, Vaitl D (1988): The International Affective Picture System (photographic slides). Gainesville, FL: The Center for Research in Psychophysiology, University of Florida.
Lautenbacher S, Roscher R, Krieg J-C (2002): Aufmerksamkeit und Befindlichkeit unter hormonell simuliertem Stress: Die Wirkung von Corticotropin-Releasing-Hormon. Zeitschrift für Neuropsychologie 13: 59–67.
Li G, Cherrier MM, Tsuang DW, Petrie EC, Colasurdo EA, Craft S et al (2006): Salivary cortisol and memory function in human aging. Neurobiol Aging 27: 1705–1714.
Lupien SJ, McEwen BS (1997): The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev 24: 1–27. Umfassender Überblick über tier-und humanexperimentelle Studien zu Effekten von Kortikosteroiden auf kognitive Funktionen mit dem Versuch einer Integration im Hinblick auf die Rolle der zwei Kortikosteroidrezeptortypen, GR und MR. GR spielen demnach v. a. eine Rolle bei der Gedächtniskonsolidierung, während MR Einfluss auf Aktivierungs-und Aufmerksamkeitsprozesse nehmen.
Lupien SJ, Gaudreau S, Tchiteya BM, Maheu F, Sharma S, Nair NP et al (1997): Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab 82: 2070–2075.
Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP et al (1998): Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1: 69–73.
Lupien SJ, Gillin CJ, Hauger RL (1999): Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 113: 420–430.
Lupien SJ, Wilkinson CW, Briere S, Menard C, Ng Ying Kin NM, Nair NP (2002): The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 27: 401–416.
Maheu FS, Joober R, Beaulieu S, Lupien SJ (2004): Differential effects of adrenergic and corticosteroid hormonal systems on human short-and long-term declarative memory for emotionally arousing material. Behav Neurosci 118: 420–428.
Maheu FS, Collicutt P, Kornik R, Moszkowski R, Lupien SJ (2005): The perfect time to be stressed: a differential modulation of human memory by stress applied in the morning or in the afternoon. Prog Neuropsychopharmacol Biol Psychiatry 29: 1281–1288.
McGaugh JL (2000): Memory-a century of consolidation. Science 287: 248–251.
Mölle M, Albrecht C, Marshall L, Fehm HL, Born J (1997a): Adrenocorticotropin widens the focus of attention in humans. A nonliner electroencephalographic analysis. Psychosom Med 59: 497–502.
Mölle M, Pietrowsky R, Fehm HL, Born J (1997b): Regulation of human thought by neuropeptide ACTH 4-10: an analysis of the EEG’s dimensional complexity. Neuroreport 8: 2715–2720.
Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K et al (1984): Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226: 1342–1344.
Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME (1994): Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14: 2047–2053.
Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K et al (1999): Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56: 527–533.
Oitzl MS, de Kloet ER (1992): Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 106: 62–71.
Pelleymounter MA, Joppa M, Ling N, Foster AC (2004): Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25: 659–666.
Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M et al (2004): The selfish brain: competition for energy resources. Neurosci Biobehav Rev 28: 143–180.
Pietrowsky R, Krug R, Fehm HL, Born J (1992): Der Einfluß von „Streßhormonen“ auf die emotionale Befindlichkeit. Zeitschrift für experimentelle und angewandte Psychologie 39: 278–298.
Plihal W, Born J (1997): Effects of early and late nocturnal sleep on declarative and procedural memory. J Cogn Neurosci 9: 534–547.
Plihal W, Born J (1999a): Memory consolidation in human sleep depends on inhibition of glucocorticoid release. Neuroreport 10: 2741–2747.
Plihal W, Born J (1999b): Effects of early and late nocturnal sleep on priming and spatial memory. Psychophysiology 36: 571–582.
Plihal W, Krug R, Pietrowsky R, Fehm HL, Born J (1996): Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 21: 515–523.
Plihal W, Pietrowsky R, Born J (1999): Dexamethasone blocks sleep induced improvement of declarative memory. Psychoneuroendocrinology 24: 313–331.
de Quervain DJ, Roozendaal B, McGaugh JL (1998): Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394: 787–790.
de Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C (2000): Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 3: 313–314.
Reuter M (2002): Impact of cortisol on emotions under stress and nonstress conditions: a pharmacopsychological approach. Neuropsychobiology 46: 41–48.
Rimmele U, Domes G, Mathiak K, Hautzinger M (2003): Cortisol has different effects on human memory for emotional and neutral stimuli. Neuroreport 14: 2485–2488.
Rockstroh B, Elbert T, Lutzenberger W, Birbaumer N, Voigt KH, Fehm HL (1983): Distractability under the influence of an ACTH 4-9 derivative. Int J Neurosci 22: 21–36.
Roozendaal B (2000): Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25: 213–238. Detaillierte Darstellung der Befundlage zur Rolle von Glukokortikoiden für die Gedächtniskonsolidierung bei Ratten. Im Mittelpunkt steht der neuromodulatorische Einfluss des basolateralen Kernes der Amygdala auf die Gedächtnisbildung. So blockieren Gehirnläsionen, die selektiv diesen Amygdalakern betreffen, die Glukokortikoid-induzierte Verbesserung der Gedächtniskonsolidierung, und direkte Glukokortikoidgabe in die basolaterale Amygdala verbessert Gedächtnisleistungen beim passiven Vermeiden und in Aufgaben zum räumlichen Lernen.
Roozendaal B (2002): Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 78: 578–595.
Sanchez MM, Young LJ, Plotsky PM, Insel TR (2000): Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20: 4657–4668.
Sapolsky RM (2000): Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57: 925–935.
Sapolsky RM, Romero LM, Munck AU (2000): How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21: 55–89.
Schmidt LA, Fox NA, Goldberg MC, Smith CC, Schulkin J (1999): Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology 24: 461–483.
Smith EE, Jonides J (1999): Storage and executive processes in the frontal lobes. Science 283: 1657–1661.
Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH et al (1998): Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093–1102.
Smith JW, Evans AT, Costall B, Smythe JW (2002): Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 26: 45–60.
Smolnik R, Molle M, Fehm HL, Born J (1999): Brain potentials and attention after acute and subchronic intranasal administration of ACTH 4-10 and desacetyl-alpha-MSH in humans. Neuroendocrinology 70: 63–72.
Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U et al (2006): Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci USA103: 5585–5590.
Squire LR (1992): Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans [published erratum appears in Psychol Rev 1992 Jul;99(3):582]. Psychol Rev 99: 195–231.
Steptoe A, Wardle J (2005): Positive affect and biological function in everyday life. Neurobiol Aging 26 Suppl 1: 108–112.
Stickgold R (2005): Sleep-dependent memory consolidation. Nature 437: 1272–1278.
Strachan MW (2005): Insulin and cognitive function in humans: experimental data and therapeutic considerations. Biochem Soc Trans 33: 1037–1040.
Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK et al (1998): Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1110ee comments]. Nat Genet 19: 162–166.
Tops M, so van der PG, Baas D, Mulder LJ, Den Boer JA, Meijman TF et al (2003): Acute cortisol effects on immediate free recall and recognition of nouns depend on stimulus valence. Psychophysiology 40: 167–173.
Vedhara K, Hyde J, Gilchrist ID, Tytherleigh M, Plummer S (2000): Acute stress, memory, attention and cortisol. Psychoneuroendocrinology 25: 535–549.
Wagner U, Born J (2000): Neurochemische Emotionssysteme. In Otto JH, Euler HA, Mandl H, (eds) Emotionspsychologie: Ein Handbuch. Weinheim: Psycholgie Verlags Union.
Wagner U, Gais S, Born J (2001): Emotional memory formation is enhanced across sleep intervals with high amounts of rapid eye movement sleep. Learn Mem 8: 112–119.
Wagner U, Gais S, Haider H, Verleger R, Born J (2004): Sleep inspires insight. Nature 427: 352–355.
Wagner U, Degirmenci M, Drosopoulos S, Perras B, Born J (2005): Effects of cortisol suppression on sleep-associated consolidation of neutral and emotional memory. Biol Psychiatry 58: 885–893.
Walker MP, Brakefield T, Hobson JA, Stickgold R (2003): Dissociable stages of human memory consolidation and reconsolidation. Nature 425: 616–620.
de Wied D, van Ree JM (1989): Neuropeptides: animal behaviour and human psychopathology. Eur Arch Psychiatry Neurol Sci 238: 323–331.
Wolf OT (2003): Cognitive functions and sex steroids. Ann Endocrinol (Paris) 64: 158–161.
Wolf OT, Kirschbaum C (1999): Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev 30: 264–288.
Wolf OT, Kuhlmann S, Buss C, Hellhammer DH, Kirschbaum C (2004): Cortisol and memory retrieval in humans: influence of emotional valence. Ann N Y Acad Sci 1032: 195–197.
Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997): Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann NY Acad Sci 823: 81–96.
Wolkowitz OM, Reus VI (1999): Treatment of depression with antiglucocorticoid drugs. Psychosom Med 61: 698–711.
Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1999): The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 145: 260–266.
Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN (2004): Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 29: 1538–1545.
Zorawski M, Blanding NQ, Kuhn CM, LaBar KS (2006): Effects of stress and sex on acquisition and consolidation of human fear conditioning. Learn Mem 13: 441–450.
Zorrilla EP, Koob GF (2004): The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13: 799–828.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wagner, U., Born, J. (2010). Psychoendokrine Aspekte neuropsychologischer Funktionen: Die Hypothalamus-Hypophysen-Nebennierenrinden-Achse. In: Lautenbacher, S., Gauggel, S. (eds) Neuropsychologie psychischer Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72340-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-72340-0_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-72339-4
Online ISBN: 978-3-540-72340-0
eBook Packages: Humanities, Social Science (German Language)